Navigation Links
New potential therapeutic target discovered for genetic disorder -- Barth syndrome
Date:3/2/2009

ration, abnormal mitochondria, and poor motor function. In this new study researchers documented that tafazzin or cardiolipin deficiency in Drosophila disrupts the final stage of spermatogenesis causing male sterility. Using this fly model, the study showed that this trait of cardiolipin deficiency can be genetically suppressed by inactivating calcium-independent phospholipase A2, which prevents the degradation of cardiolipin. This method keeps cardiolipin levels normal. Researchers were also able to show that treatment of BTHS patients lymphoblasts within a tissue culture with the iPLA2-VIA inhibitor BEL partially restored the tissue cultures cardiolipin homeostasis.

"Taken together, our two findings establish a causal role of cardiolipin deficiency in the pathogenesis of Barth syndrome and identify iPLA2-VIA as a very important enzyme," said Michael Schlame, M.D., associate professor of anesthesiology and cell biology, NYU Langone Medical Center. "This is good news for patients since this enzyme is now a potential target for therapeutic intervention."

According to researchers, although this has not been tested in humans, the successful restoration of these mutated cells with BEL shows promise for continued BTHS research, patients and their families. There are no treatments for Barth syndrome at this time.


'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes
2. Tiny tool to control growing blood vessels opens new potential in tumor research
3. High CO2 boosts plant respiration, potentially affecting climate and crops
4. Potential new herpes therapy studied
5. Research finds new cause of ozone wheezing and potential treatments
6. LSUSHC researchers find potential new target for hypertension treatment
7. Genome sequence shows sorghums immense potential
8. Researchers identify potential new weapon in battle against HIV infection
9. Potential therapy for congenital muscular dystrophy
10. UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technology
11. Pitt researchers create non-toxic clean-up method for potentially toxic nano materials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...standing how sounds associated with Navy sonar mig...ey hear it at all. , The same type of large indu...ct flaws in the space shuttle,s behemoth solid fue...e the giant head of a whale. The scans are providi...s hearing anatomy using a breakthrough method deve...
(Date:11/24/2009)... Toxicology (ACMT) have signed an agreement to col...ical Toxicology (JMT), the official journal of th...y published by the University of Pennsylvania Pres...ternational, peer-reviewed journal, is dedicated t...xicology. The quarterly journal focuses on the di...
(Date:11/24/2009)...arch on bacterial communities throughout six large...ral patterns, suggesting that scientists could use...te change in the polar regions. The study, publish...cademy of Sciences Early Edition, shows that bact...onously over time, correlating with seasonal shift...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Nick Jonas 3A Livin the Dream Despite Diabetes 55255 1Nick Jonas 3A Livin the Dream Despite Diabetes 55255 2Nick Jonas 3A Livin the Dream Despite Diabetes 55255 3Nick Jonas 3A Livin the Dream Despite Diabetes 55255 4Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 1Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 2Jani King Recognized as Best in Support by the International Business Awards 55247 1Jani King Recognized as Best in Support by the International Business Awards 55247 2
...meaning to watching out for other mothers, kids. ...deer conducted by the University of Alberta in Edm...so in Canada, showed that both species responded t... the responses elicited when coyotes attack fawns,...il and mule deer calls, even when their own fawn s...
...rom the National Institutes of Health (NIH), resea...eveloping a physics-based virtual model that can s...sed in conjunction with existing 3-D models, addin... improve the accuracy and effectiveness of radiati...orge Xu, professor of nuclear and biomedical engin...
...h hungry bats, good-tasting moths increase their c...r bad-tasting cousins, according to a new Wake For...sue of the Proceedings of the National Academy of ...how how an animal species uses acoustic mimicry as...cted by Jesse Barber, a doctoral student in biolog...
Other Biology News:Mule deer moms rescue other fawns 2'Virtual Patient' to simulate real-time organ motions for radiation therapy 2Moths mimic sounds to survive 2
(Date:11/24/2009)...wswire/--BlueMarbleEnergyCorp.announcedtodaythatth...A)wererecentlyawarded$2millionbyWashingtonState,sC...e/publicpartnershiptoconstructthestate,sfirstspeci..., "Thisinvestmentwillsignificantlyspeedthedevelopm...nCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wear...
(Date:11/24/2009)...9/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc....eduledtopresentatthePiperJaffray21stAnnualHealthCa...(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewY...veOfficer,isscheduledtoprovideanoverviewofthecompa...rams. ,, Aliveaudiowebcastofthepresentationwill...
(Date:11/24/2009)...wswire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasd...PiperJaffrayHealthCareConference.Theconferencewill..., CTIwillpresentonTuesday,December1at11:00a.m.Ea...I,spresentationwillbeavailableat www.celltherapeut...ds. , ,PiperJaffrayHealthCareConference,NewYorkPa...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(P...lishedNovember27,2009astheex-dividenddateforits$20...thesecuritizationtransactioncompletedonNovember2,2...ckholdersofrecordontherecorddate,December1,2009.NA...dat$1.67pershareofcommonstockforpurposesoftheex-di...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... Austria, November 28 f-star, an antibody,enginee...ody fragments,based on its unique Modular Antibody...R 3.0 million from Novo A/S in a Second Closing of...y Aescap Venture and Atlas Venture.,After this Sec...nd,increases to EUR 9.0 million. In total, the Com...
... from animal model testing demonstrate ANAVEX 1-41... anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswi...X") (OTCBB: AVXL) is pleased to announce promising... drug candidate for Alzheimer,s disease. In,recent...d oxidative stress,which damages and destroys cell...
... France, November 28 The results of a,study on ch...asses,sublingual desensitisation product, which is...y., The phase III paediatric study, VO52.06, whic...untries suffering from allergic,rhino-conjunctivit...onstrating a statistically significant reduction i...
Other Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study 2
... 2, Monoclonal Antibody, Unconjugated Applicati...ICC: Use at an assay dependent dilution. WB: Use a...ion is determined using a whole extract of rat bra... in other applications. Optimal dilutions/concent...
Mouse Anti-G alpha o Monoclonal Antibody, Unconjugated, Clone 1C.2 from Sigma-Aldrich
Anti-SHP-2 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human PPAR gamma 2 Monoclonal Antibody, Unconjugated, Clone K8450B from Cosmo Bio Co., Ltd.
Biology Products: